For enrolled patients, SPECT-CT images are collected by QIPCM at every cycle of 177Lu-Dota therapy using the QIPCM-issued image de-identification and transfer pipeline. Specified delegates were granted permission to view and contour this trial’s images on the QIPCM platform. QIPCM developed an extended workflow in MIM software so that physicians can themselves draw and process contours to generate dosimetry reports in PDF format. Each report can then be reviewed by a physicist and a physician.
† 68Ga (for diagnosis) and 177Lu-Dota (for therapy) both target cell surface somatostatin receptors (SSTCs) which are commonly expressed in NETs.